Applied Cells

Don't miss our poster presentation TODAY! ➡️ 𝗣𝗼𝘀𝘁𝗲𝗿 #𝟮𝟯𝟳𝟮 — Clinical trial result update on GoFast™ CAR-T treating severe, refractory Myasthenia Gravis: method, efficacy, speed, & cost 🗓 Wednesday 05/13/2026 🕔 5:00 PM–6:30 PM ⭐ Can't miss! #ASGCT2026 #CellTherapy

Join Applied Cells at #ASGCT2026 at 𝗣𝗼𝘀𝘁𝗲𝗿 #𝟮𝟯𝟳𝟮, presented by Yuchen Zhou, CEO & Founder, featuring new data on a rapid GoFast™ BCMA/CD19 dual-targeting CAR-T approach for patients with severe, refractory myasthenia gravis. See Full Details: na2.hubs.ly/H05t7Rd0

Join Applied Cells at #ASGCT2026 at 𝗣𝗼𝘀𝘁𝗲𝗿 #𝟮𝟯𝟳𝟮, presented by Yuchen Zhou, CEO & Founder, featuring new data on a rapid GoFast™ BCMA/CD19 dual-targeting CAR-T approach for patients with severe, refractory myasthenia gravis. See Full Details: na2.hubs.ly/H05qnyW0

It's #ASGCT2026 week, and we have poster presentations tomorrow AND Wednesday that you won't want to miss! ➡️ 𝗣𝗼𝘀𝘁𝗲𝗿 #𝟭𝟭𝟵𝟳 | 05/12/2026 |5:00 PM–6 PM ➡️ 𝗣𝗼𝘀𝘁𝗲𝗿 #𝟮𝟯𝟳𝟮 | 05/13/2026 | 5:00 PM–6:30 PM See Full Details: na2.hubs.ly/H05qnQs0 #CART #CellTherapy

We’ve been awarded U.S. Patent No. 12,595,460 B2 covering key methods and instrumentation for CAR-T cell production that support our GoFast™ manufacturing approach. Read the full announcement here: na2.hubs.ly/H05f_700 #CellTherapy #CART #AdvancedTherapies #Innovation

We've expanded our MARS® Ingenuity™ Line of reagents! 🎉 The MARS® Ingenuity™ line has expanded to include CD34 Nanobeads, TCR α/β Nanobeads, and CD56 Nanobeads, now available in both RUO and GMP formats. Discover our latest additions!: na2.hubs.ly/H05c9470 #celltherapy

On April 8, 2026, the MARS Bar platform was showcased at the ceremonial opening of the new facilities of the Centre of Excellence CREATIC at Masaryk University’s Faculty of Medicine in Brno. Read the full announcement here➡️: na2.hubs.ly/H052YBj0 #celltherapy #rarediseases

💡 Discover our latest brochure to see how the MARS® Bar Flex helps streamline cell separation with high performance and minimal handling ➡️ na2.hubs.ly/H04NrF70 #immunotherapy #AdvancedTherapies #cellisolation

Discover our latest blog: From treating one to treating all: rethinking the economics of autologous CAR-T 🔗 Read more to see how autologous CAR-T is evolving to meet this moment: na2.hubs.ly/H04KxRW0 #CARTmanufacturing #celltherapy #CARTcelltherapy #healthcareinnovation

Take your cell isolation to new levels. Designed with cost & high performance in mind, MARS is the solution for your cell isolation needs. ✔️ Customizable workflow ✔️ Compatible with traditional & fast CAR-T protocols ✔️ ISO13485:2016 certified Learn more: na2.hubs.ly/H04w-tS0

Imagine knowing a life-saving treatment exists —but it costs over $300,000 and takes weeks to produce. GoFast™ aims to change that: 💡 Manufacturing reduced to 3 days 💡 Lower production cost 💡 Greater potential access worldwide Discover more here: na2.hubs.ly/H03YqDK0

Read our latest blog where we discuss affordability for the future of cell therapy: • COGS < $10k could unlock broader access • Decentralized models reduce infrastructure burden • Affordability defines CAR-T 2.0 Read our full blog here ➡️: na2.hubs.ly/H03YmbS0 #celltherapy

Speed is the tool—but only when it can be repeated. For CAR-T to reach patients everywhere, speed must be repeatable, controlled, and reliable. Automation and closed systems make rapid manufacturing scalable. This is speed with purpose. GoFast™ with us ➡️ na2.hubs.ly/H03LxRX0

Happy Lunar New Year! As we welcome the New Year, we wish our colleagues, partners, and community continued growth, collaboration, and success. May the year ahead bring prosperity, good health, and new opportunities for all. #LunarNewYear #YearOfTheHorse #NewBeginnings

Our GoFast™ workflow is changing the game in CAR-T manufacturing, bringing next-level innovation, precision, and hope. Different arena. Same goal: delivering results when it matters most 🏆🏈 Discover the game-changing innovation of CAR-T: na2.hubs.ly/H03pWsY0 #celltherapy

GoFast™ is about designing a manufacturing workflow where speed, flexibility, and cost reduction move together. GoFast™ with us and make affordable CAR-T a reality for patients who need it most. Discover More: hubs.li/Q040qqCS0 #CARTcelltherapy #cancer #CARTmanufacturing

Our CAR-T mission is accessibility across global regions and healthcare systems. Speed is the tool. $10k COGS is the goal. Accessibility is the mission. GoFast™ with us. 👉 Here’s how: hubs.li/Q03_ngJs0 #celltherapy #CARTmanufacturing

CAR-T isn’t limited by science. It’s limited by cost. Affordability decides how far access can go. Bring your COGS below $10,000 with us this year and GoFast™! Learn how ➡️: hubs.li/Q03_cNYz0 #CARTmanufacturing #celltherapy #cellmanufacturing #precisionmedicine

CAR-T has proven its science. Now comes affordability, scale, & sustainability. If COGS < $10k is part of the future, this year matters. Start your year with GoFast™➡️ hubs.li/Q03-kDFs0 #StayTuned #GoFastYear #CellTherapy #Biotech #healthcareinnovation #CARTmanufacturing

CAR-T works. The real challenge now: accessibility. In 2026, our focus shifts from proof of science → proof of access from innovation → implementation from possibility → practicality Start your year with GoFast™ ➡️ hubs.li/Q03ZzdpD0 #celltherapy #CARTmanufacturing